Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021

SELL
$70.31 - $77.77 $5.42 Million - $6 Million
-77,102 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$68.86 - $81.11 $33,947 - $39,987
-493 Reduced 0.64%
77,102 $5.94 Million
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $366,744 - $407,011
5,110 Added 7.05%
77,595 $6.35 Million
Q3 2020

Oct 23, 2020

SELL
$73.18 - $82.95 $95,938 - $108,747
-1,311 Reduced 1.78%
72,485 $5.83 Million
Q2 2020

Jul 17, 2020

BUY
$70.42 - $80.13 $538,713 - $612,994
7,650 Added 11.57%
73,796 $5.66 Million
Q1 2020

Apr 30, 2020

BUY
$63.36 - $87.82 $65,387 - $90,630
1,032 Added 1.58%
66,146 $5.52 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $54,693 - $61,715
-705 Reduced 1.07%
65,114 $5.92 Million
Q3 2019

Oct 17, 2019

BUY
$76.08 - $82.93 $53,332 - $58,133
701 Added 1.08%
65,819 $5.54 Million
Q2 2019

Jul 30, 2019

BUY
$69.84 - $81.59 $4.45 Million - $5.2 Million
63,696 Added 4479.32%
65,118 $5.46 Million
Q1 2019

May 02, 2019

SELL
$69.58 - $79.36 $42,095 - $48,012
-605 Reduced 29.85%
1,422 $118,000
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $23,160 - $26,877
355 Added 21.23%
2,027 $147,000
Q3 2018

Oct 22, 2018

BUY
$57.69 - $67.84 $96,457 - $113,428
1,672 New
1,672 $118,000
Q2 2018

Jul 13, 2018

SELL
$50.83 - $59.72 $26,329 - $30,934
-518 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $12,905 - $15,410
-250 Reduced 32.55%
518 $29,000
Q3 2017

Nov 03, 2017

SELL
$58.67 - $63.13 $14,667 - $15,782
-250 Reduced 24.56%
768 $49,000
Q2 2017

Aug 11, 2017

BUY
N/A
1,018
1,018 $65,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wespac Advisors So Cal, LLC Portfolio

Follow Wespac Advisors So Cal, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.